» Articles » PMID: 36068370

Advances in Glycolysis Metabolism of Atherosclerosis

Overview
Publisher Springer
Date 2022 Sep 6
PMID 36068370
Authors
Affiliations
Soon will be listed here.
Abstract

Glycolysis is an important way for various cells such as vascular wall endothelial cells, smooth muscle cells, macrophages, and other cells to obtain energy. In pathological conditions, it can participate in the process of AS by regulating lipid deposition, calcification, angiogenesis in plaques, etc., together with its metabolite lactic acid. Recent studies have shown that lactate-related lactylation modifications are ubiquitous in the human proteome and are involved in the regulation of various inflammatory diseases. Combined with the distribution and metabolic characteristics of cells in the plaque in the process of AS, glycolysis-lactate-lactylation modification may be a new entry point for targeted intervention in atherosclerosis in the future. Therefore, this article intends to elaborate on the role and mechanism of glycolysis-lactate-lactylation modification in AS, as well as the opportunities and challenges in targeted therapy, hoping to bring some help to relevant scholars in this field. In atherosclerosis, glycolysis, lactate, and lactylation modification as a metabolic sequence affect the functions of macrophages, smooth muscle cells, endothelial cells, lymphocytes, and other cells and interfere with processes such as vascular calcification and intraplaque neovascularization to influence the progression of atherosclerosis.

Citing Articles

New Types of Post-Translational Modification of Proteins in Cardiovascular Diseases.

Fang J, Wu S, Zhao H, Zhou C, Xue L, Lei Z J Cardiovasc Transl Res. 2025; .

PMID: 40032789 DOI: 10.1007/s12265-025-10600-7.


Protein posttranslational modifications in metabolic diseases: basic concepts and targeted therapies.

Yang Y, Wu J, Zhou W, Ji G, Dang Y MedComm (2020). 2024; 5(10):e752.

PMID: 39355507 PMC: 11442990. DOI: 10.1002/mco2.752.


Immune, Oxidative, and Morphological Changes in the Livers of Tibetan Sheep after Feeding Resveratrol and β-Hydroxy-β-methyl Butyric Acid: A Transcriptome-Metabolome Integrative Analysis.

Chen X, Zhang F, Raza S, Wu Z, Su Q, Ji Q Int J Mol Sci. 2024; 25(18).

PMID: 39337353 PMC: 11432669. DOI: 10.3390/ijms25189865.


Lactate dehydrogenase A (LDHA)-mediated lactate generation promotes pulmonary vascular remodeling in pulmonary hypertension.

Wu D, Wang S, Wang F, Zhang Q, Zhang Z, Li X J Transl Med. 2024; 22(1):738.

PMID: 39103838 PMC: 11302077. DOI: 10.1186/s12967-024-05543-7.


The role of lactate-induced protein lactylation in gliomas: implications for preclinical research and the development of new treatments.

Liu X, Zhou Y, Wang H Front Pharmacol. 2024; 15:1383274.

PMID: 38983918 PMC: 11231103. DOI: 10.3389/fphar.2024.1383274.


References
1.
Fan J, Watanabe T . Atherosclerosis: Known and unknown. Pathol Int. 2022; 72(3):151-160. DOI: 10.1111/pin.13202. View

2.
Xiangdong L, Yuanwu L, Hua Z, Liming R, Qiuyan L, Ning L . Animal models for the atherosclerosis research: a review. Protein Cell. 2011; 2(3):189-201. PMC: 4875304. DOI: 10.1007/s13238-011-1016-3. View

3.
Oorni K, Rajamaki K, Nguyen S, Lahdesmaki K, Plihtari R, Lee-Rueckert M . Acidification of the intimal fluid: the perfect storm for atherogenesis. J Lipid Res. 2014; 56(2):203-14. PMC: 4306676. DOI: 10.1194/jlr.R050252. View

4.
van Tuijl J, Joosten L, Netea M, Bekkering S, Riksen N . Immunometabolism orchestrates training of innate immunity in atherosclerosis. Cardiovasc Res. 2019; 115(9):1416-1424. PMC: 6910162. DOI: 10.1093/cvr/cvz107. View

5.
Foks A, Bot I . Preface: Pathology and Pharmacology of Atherosclerosis. Eur J Pharmacol. 2017; 816:1-2. DOI: 10.1016/j.ejphar.2017.10.052. View